Foghorn Therapeutics (FHTX) EPS (Basic) (2019 - 2026)
Foghorn Therapeutics (FHTX) posted quarterly EPS (Basic) of -$1.16 for Q1 2026, down 217.11% year-over-year from $0.99 in Q1 2025, and down 206.24% quarter-over-quarter from -$0.38 in Q4 2025.
Powered by 
Analysis
Foghorn Therapeutics (FHTX) EPS (Basic) (2019 - 2026) Analysis & Trends
Foghorn Therapeutics' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$1.16 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 217.11% year-over-year to -$1.16; the TTM figure through Mar 2026 stood at -$3.25 (down 141.5% YoY), while the FY2025 annual figure was -$4.21, down 166.96% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.16, down from -$0.38 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.31 in Q3 2024, with the low at -$1.27 in Q2 2025.
- The 5-year median for EPS (Basic) is -$0.62 (2022), against an average of -$0.62.
- The sharpest annual moves came in 2022 and 2026: EPS (Basic) jumped 77.21% in 2022, then sank 217.11% in 2026.
- Foghorn Therapeutics' EPS (Basic) stood at -$0.69 in 2022, then gained by 17.31% to -$0.57 in 2023, then jumped by 38.14% to -$0.36 in 2024, then retreated by 6.59% to -$0.38 in 2025, then sank by 206.24% to -$1.16 in 2026.
- Business Quant data shows FHTX's EPS (Basic) at -$1.16 in Q1 2026, -$0.38 in Q4 2025, and -$0.66 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Foghorn Therapeutics | 346.08 Mn | 278.00 Mn | - | -0.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.10 |
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.35 |
| Sep 30, 2025 | -0.26 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.32 |
| Dec 31, 2024 | -0.36 |
| Sep 30, 2024 | -0.31 |
| Jun 30, 2024 | -0.45 |
| Mar 31, 2024 | -0.59 |
| Dec 31, 2023 | -0.57 |
| Sep 30, 2023 | -0.34 |
| Jun 30, 2023 | -0.70 |
| Mar 31, 2023 | -0.73 |
| Dec 31, 2022 | -0.69 |
| Sep 30, 2022 | -0.62 |
| Jun 30, 2022 | -0.66 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | -0.77 |
| Sep 30, 2021 | -0.72 |